- Professor Michael Kidd AM, Deputy Chief Medical Officer, Department of Health
- Dr Karen Price, President of the Royal Australian College of General Practitioners
Live Captions are available for this webinar.
Resources and information
- TGA provisionally approves two oral COVID-19 treatments, molnupiravir (LAGEVRIO) and nirmatrelvir + ritonavir (PAXLOVID)
- The Australian Government - TGA’s provisional approval of COVID-19 oral medications
- Coronavirus National Helpline: 1800 020 080; it operates 24 hours a day, seven days a week
- National COVID-19 Clinical Evidence Taskforce – Caring for people with COVID-19
To keep up to date about upcoming webinars, subscribe to our weekly Primary Care announcements and newsletters.